How to Deal with Complexity of Nanomedicine in Practice

Authors

  • Stefan Mühlebach Department of Pharmaceutical Sciences, Division of Clinical Pharmacy & Epidemiology, Hospital Pharmacy, 
University of Basel, Basel, Switzerland https://orcid.org/0000-0002-8471-7513

DOI:

https://doi.org/10.33892/aph.2021.91.114-116

Keywords:

Nanomedicine and nanopharmaceuticals, NBCDs, regulatory challenges, educational need

Published

2021-11-15

How to Cite

(1)
Mühlebach, S. How to Deal With Complexity of Nanomedicine in Practice. Acta Pharm Hung 2021, 91, 114-116.

Issue

Vol. 91 No. 3-4 (2021): Abstracts of DDRS 2021 Conference, November 15-17, 2021, Budapest, Hungary

Section

Short communication

Copyright (c) 2021 Acta Pharmaceutica Hungarica

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

APH is published as a diamond open-access journal under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Creative Commons License